Table 3. Overview of CMVpp52 antibody status and CMVpp52-specific T-cells in SLE patients and healthy controls.

	CMVpp52-specific (CD69) T-cells			CMVpp52 antibodies
	Total	CD8+	CD8-	IgG	IgM	IgA
SLE patients (n = 17), %	24	12	18	35	35	59
Healthy controls (n = 17), %	100	82	88	18	47	29
Comparison by Fisher’s exact test, p-values	<0.0001	<0.0001	<0.0001	0.44	0.73	0.17